@article{1a7fe2ffb92c47949dcddf229b0430fb,
title = "Erratum to: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells (Nature Communications, (2017), 8, 1, (562), 10.1038/s41467-017-00627-z)",
abstract = "The original version of this Article omitted a declaration from the competing interests statement, which should have included the following: {\textquoteleft}R.D.S. is a cofounder, stock holder, and scientific advisory board member of Jounce Therapeutics and Neon Therapeutics, and a member of the scientific advisory boards of BioLegend, Constellation, Lytix, and NGM. He also received research funding from Janssen and Agios.{\textquoteright}. This has now been corrected in both the PDF and HTML versions of the Article.",
author = "M. Fehlings and Y. Simoni and Penny, {H. L.} and E. Becht and Loh, {C. Y.} and Gubin, {M. M.} and Ward, {J. P.} and Wong, {S. C.} and Schreiber, {R. D.} and Newell, {E. W.}",
note = "Funding Information: The original version of this Article omitted a declaration from the competing interests statement, which should have included the following: {\textquoteleft}R.D.S. is a cofounder, stock holder, and scientific advisory board member of Jounce Therapeutics and Neon Therapeutics, and a member of the scientific advisory boards of BioLegend, Constellation, Lytix, and NGM. He also received research funding from Janssen and Agios.{\textquoteright}. This has now been corrected in both the PDF and HTML versions of the Article. Publisher Copyright: {\textcopyright} 2018, The Author(s).",
year = "2018",
month = dec,
day = "1",
doi = "10.1038/s41467-018-05468-y",
language = "English",
volume = "9",
journal = "Nature communications",
issn = "2041-1723",
number = "1",
}